A photo from open sources
Artificial intelligence will analyze biomaterials patients and make a diagnosis. In 2021, AI is planned to be introduced in the work of clinics. According to the publication RIA “Novosti” with reference to AI developer company CoBrain-Analytics.
Artificial intelligence will study blood, urine and samples tissues obtained from patients with various diseases. Will be cancer patients and neurodegenerative diseases. Subsequently received the results will be checked against the clinical data of other medical institutions, and then the patient will be assigned a personal treatment.
AI developers say that the patient will undergo preliminary tests, and only then he will be prescribed personal treatment. Taking advantage the accumulated AI data will be able to create new drugs.
ESOREITER previously talked about American biotechnology a company that plans to bring patients back to life using stem cells and laser stimulation.
Andrey Vetrov
Artificial Intelligence
